Clinical Trial Update: Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome and non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Polycystic Ovary Syndrome

Drugs mentioned

• Canagliflozin (canagliflozin)
• metformin (metformin)

Snippet

Sponsor: Ping Li,MD | Conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease | Phase 4 | Status: UNKNOWN